Publication | Closed Access
Reduction of mortality by sulphinpyrazone after experimental myocardial infarction in the rat
11
Citations
2
References
1980
Year
Heart FailureCardiovascular PharmacologyPharmacotherapyCardiovascular ToxicityTranslational PharmacologyCardiovascular Translational ResearchSystems PharmacologyMolecular PharmacologyPre-clinical PharmacologyPharmacological StudyAtherosclerosisExperimental Myocardial InfarctionMyocardial InfarctionMedicinePharmacologyCardiovascular DiseasePhysiologyCardiovascular PharmacodynamicsBiological Research LaboratoriesJournal Article ReductionDrug Discovery
Journal Article Reduction of mortality by sulphinpyrazone after experimental myocardial infarction in the rat Get access L Brunner, L Brunner Biological Research Laboratories, Pharmaceuticals Division, CIBA-GEIGY Limited, Basle, Switzerland Correspondence: Biological Research Laboratories, Pharmaceuticals Division, CIBA-GEIGY Limited, Basle, Switzerland Search for other works by this author on: Oxford Academic Google Scholar J Stepanek, J Stepanek Biological Research Laboratories, Pharmaceuticals Division, CIBA-GEIGY Limited, Basle, Switzerland Search for other works by this author on: Oxford Academic Google Scholar H Brunner H Brunner Biological Research Laboratories, Pharmaceuticals Division, CIBA-GEIGY Limited, Basle, Switzerland Search for other works by this author on: Oxford Academic Google Scholar Journal of Pharmacy and Pharmacology, Volume 32, Issue 1, September 1980, Pages 714–715, https://doi.org/10.1111/j.2042-7158.1980.tb13047.x Published: 12 April 2011 Article history Received: 15 February 1980 Published: 12 April 2011
| Year | Citations | |
|---|---|---|
Page 1
Page 1